Specialties
The PaceNew therapies / indications available since the last 12 months 
DESPAXOR
BY: Dr. Feng XueOct 24, 2025
ENTECAVIR TEVA
BY: Dr. Feng XueOct 24, 2025
HYMPAVZI
BY: Dr. Feng XueOct 24, 2025
LYTGOBI
BY: Dr. Feng XueOct 24, 2025
CALQUENCE®
BY: Dr. Feng XueAug 14, 2025
GLUCOPHAGE XR®
BY: Dr. Feng XueAug 14, 2025
JUBBONTI®
BY: Dr. Feng XueAug 14, 2025
APIXABAN TEVA®
BY: Dr. Feng XueAug 14, 2025
WEZLANA®
BY: Dr. Feng XueJun 13, 2025
LINAGLIPTIN TAISHO®
BY: Dr. Feng XueJun 13, 2025
PAZOPANIB TEVA®
BY: Dr. Feng XueJun 13, 2025
RYZODEG®
BY: Dr. Feng XueJun 13, 2025
Popular Story
Rheumatology in 2025: Breakthroughs, Technologies, and the Future of Care
  • Dr. Feng Xue
  • Oct 24, 2025
V.Pulse 032 Issue is published!
  • Vital Base International Limited
  • Oct 24, 2025
Breaking the Pathologic Combo of CVD and T2DM – Now and Then
  • Dr. Roy Lau
  • Aug 14, 2025
No More Itch – Uncovering Urticaria and Its Clinical Management
  • Dr. Roy Lau
  • Jun 13, 2025
What Should We Know About Anxiety Disorder?
  • Dr. Roy Lau
  • Apr 11, 2025
Uncovering the Art of Perfect Matching – A Review on Precision Oncology
  • Dr. Roy Lau
  • Feb 17, 2025
Specialties
More Contents
©2025 V-Pulse. All rights reserved.